Skip to main content
SpringerLink
Log in

Modeling Gliomagenesis with Somatic Cell Gene Transfer using Retroviral Vectors

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Modeling brain tumor formation in experimental animals with somatic cell gene transfer has a long history. In the early experiments naturally occurring retroviruses were used to induce primary brain tumors in a variety of test animals. The subsequent identification of the v-src oncogene within RSV and other cellular proto-oncogenes encoded by other retroviruses moved the field of oncology into the molecular age. Recombinant retroviruses were originally used to infect cells in vitro followed by transplantation. Since then, retroviral vectors have been used to generate glioma formation in vivo via intracerebral injection of neonatal mice. In the most recent models, primary brain tumors can be induced by injecting avian recombinant retroviruses containing different oncogenes, individually or in combination, into transgenic mice genetically engineered for susceptibility to retroviral gene transfer targeting specific cell types in the brain. Animal modeling experiments have contributed substantially to the understanding of the etiology leading to gliomagenesis. The current models provide tumors, which are genetically and histologically similar to their human counterparts, making them attractive to use in drug discovery for treatment of gliomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ellerman V, Bang O: Experimentelle leukämie bei hühnern. Zentralbl Bakteriol Parasitenkd Infectionskr Hyg Abt Orig 46: 595–609, 1908

    Google Scholar 

  2. Rous P: A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 13: 397–411, 1911

    Google Scholar 

  3. Keogh EV: Ectodermal lesions produced by the virus of Rous sarcoma. Br J Exp Pathol 19: 1–9, 1938

    Google Scholar 

  4. Temin HM, Rubin H: Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture. Virology 6: 669–688, 1958

    Google Scholar 

  5. Temin HM: Nature of the provirus of Rous sarcoma. Natl Cancer Inst Monogr 17: 557–570, 1964

    Google Scholar 

  6. Baltimore D: RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 226: 1209–1211, 1970

    Google Scholar 

  7. Temin HM, Mizutani S: RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 226: 1211–1213, 1970

    Google Scholar 

  8. Stehelin D, Varmus HE, Bishop JM, Vogt PK: DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260: 170–173, 1976

    Google Scholar 

  9. Vogt PK, Ishizaki R: Patterns of viral interference in the avian leukosis and sarcoma complex.Virology 30: 368–374, 1966

    Google Scholar 

  10. Vasques-Lopez E: On the growth of Rous sarcoma inoculated into the brain. Amer J Cancer 26: 29–55, 1936

    Google Scholar 

  11. Rabotti GF, Raine WA: Brain tumors induced in hamsters inoculated intracerebrally at birth with Rous sarcoma virus. Nature 204: 898–899, 1964

    Google Scholar 

  12. Rabotti GF, Anderson WR, Sellers RL: Oncogenic activity of Mill Hill (Harris) strain of Rous sarcoma virus for hamsters. Nature 206: 946–947, 1965

    Google Scholar 

  13. Rabotti GF, Raine WA, Sellers RL: Brain tumors (gliomas) induced in hamsters by Bryan's strain of Rous sarcoma virus. Science 147: 504–506, 1965

    Google Scholar 

  14. Rabotti GF, Sellers RL, Anderson WA: Leptomeningeal sarcomata and gliomata induced in rabbits by Rous sarcoma virus. Nature 209: 524–526, 1966

    Google Scholar 

  15. Rabotti GF, Grove AS, Sellers RL, Anderson WR: Induction of multiple brain tumours (gliomata and leptomeningeal sarcomata) in dogs by Rous sarcoma virus. Nature 209: 884–886, 1966

    Google Scholar 

  16. Rabotti GF, Landon JC, Pry TW, Beadle L, Doll J, Fabrizio DP, Dalton AJ: Tumors in rhesus monkeys inoculated at birth with homologous cells converted in vitro by Rous sarcoma virus, Schmidt-Ruppin strain. J Natl Cancer Inst 38: 821–837, 1967

    Google Scholar 

  17. Kumanishi T: Brain tumors induced with Rous sarcoma virus, Schmidt-Ruppin strain. I. Induction of brain tumors in adult mice with Rous chicken sarcoma cells. Jpn J Exp Med 37: 461–474, 1967

    Google Scholar 

  18. Kumanishi T, Ikuta F, Yamamoto T: Brain tumors induced by Rous sarcoma virus, Schmidt-Ruppin strain. 3. Morphology of brain tumors induced in adult mice. J Natl Cancer Inst 50: 95–109, 1973

    Google Scholar 

  19. Bigner DD, Odom GL, Mahaley MS, Day ED: Brain tumors induced in dogs by the Schmidt-Ruppin strain of Rous sarcoma virus. Neuropathological and immunological observations. J Neuropathol Exp Neurol 28: 648–680, 1969

    Google Scholar 

  20. Wilfong RF, Bigner DD, Self DJ, Wechsler W: Brain tumor types induced by the Schmidt-Ruppin strain of Rous sarcoma virus in inbred Fischer rats. Acta Neuropathol 25: 196–206, 1973

    Google Scholar 

  21. Haas M, Askari A, Xie Z: Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase. J Biol Chem 275: 27832–27837, 2000

    Google Scholar 

  22. McGlade J, Cheng A, Pelicci G, Pelicci PG, Pawson T: Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases. Proc Natl Acad Sci USA 89: 8869–8873, 1992

    Google Scholar 

  23. Jones DA, Benjamin CW: Phosphorylation of growth factor receptor binding protein-2 by pp60c-src tyrosine kinase. Arch Biochem Biophys 337: 143–148, 1997

    Google Scholar 

  24. Otsu M, Hiles I, Gout I, Fry MJ, Ruiz-Larrea F, Panayotou G, Thompson A, Dhand R, Hsuan J, Totty N: Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase. Cell 65: 91–104, 1991

    Google Scholar 

  25. Maunoury R, Delpech A, Delpech B, Vidard MN, Vedrenne C, Constans JP, Hillereau J: Immunocytochemical localization of gliofibrillary proteins (GDAP) in human cerebral tumors. Histological and in vitro studies. Neurochirurgie 23: 173–185, 1977

    Google Scholar 

  26. Jacque CM, Vinner C, Kujas M, Raoul M, Racadot J, Baumann NA: Determination of glial fibrillary acidic protein (GFAP) in human brain tumors. J Neurol Sci 35: 147–155, 1978

    Google Scholar 

  27. Maunoury R, Courdi A, Vedrenne C, Constans JP: Immunocytochemical localization of the GFAP in heterotransplanted human gliomas (author's transl). Neurochirurgie 24: 221–226, 1978

    Google Scholar 

  28. Wiestler OD, Aguzzi A, Williams RL, Wagner EF, Boulter CA, Kleihues P: Tumour induction in fetal brain transplants exposed to the viral oncogenes polyoma middle T and v-src. IARC Sci Publ 96: 267–274, 1989

    Google Scholar 

  29. Aguzzi A, Kleihues P, Heckl K, Wiestler OD: Cell typespecific tumor induction in neural transplants by retrovirusmediated oncogene transfer. Oncogene 6: 113–118, 1991

    Google Scholar 

  30. Dilworth SM, Brewster CE, Jones MD, Lanfrancone L, Pelicci G, Pelicci PG: Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc. Nature 367: 87–90, 1994

    Google Scholar 

  31. Summers SA, Lipfert L, Birnbaum MJ: Polyoma middle T antigen activates the Ser/Thr kinase Akt in a PI3-kinasedependent manner. Biochem Biophys Res Commun 246: 76–81, 1998

    Google Scholar 

  32. Auger KR, Carpenter CL, Shoelson SE, Piwnica-Worms H, Cantley LC: Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro. J Biol Chem 267: 5408–5415, 1992

    Google Scholar 

  33. Wiestler OD, Aguzzi A, Schneemann M, Eibl R, von Deimling A, Kleihues P: Oncogene complementation in fetal brain transplants. Cancer Res 52: 3760–3767, 1992

    Google Scholar 

  34. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P: Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature 333: 560–562, 1988

    Google Scholar 

  35. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD: Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333: 562–565, 1988

    Google Scholar 

  36. Calver AR, Hall AC, Yu WP, Walsh FS, Heath JK, Betsholtz C, Richardson WD: Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20: 869–882, 1998

    Google Scholar 

  37. Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN: Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86: 131–140, 1990

    Google Scholar 

  38. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Nistér M: Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52: 3213–3219, 1992

    Google Scholar 

  39. Guha A, Dashner K, Black PM, Wagner JA, Stiles CD: Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer 60: 168–173, 1995

    Google Scholar 

  40. Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaronson SA, Ali IU: Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 52: 4550–4553, 1992

    Google Scholar 

  41. Kumabe T, Sohma Y, Kayama T, Yoshimoto T, Yamamoto T: Amplification of alpha-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin. Oncogene 7: 627–633, 1992

    Google Scholar 

  42. Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH: Alterations of the TP53 gene in human gliomas. Cancer Res 54: 1324–1330, 1994

    Google Scholar 

  43. Hermanson M, Funa K, Koopmann J, Maintz D, Waha A, Westermark B, Heldin CH, Wiestler OD, Louis DN, von Deimling A, Nistér M: Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas. Cancer Res 56: 164–171, 1996

    Google Scholar 

  44. Uhrbom L, Hesselager G, Nistér M, Westermark B: Induction of brain tumors in mice using a recombinant plateletderived growth factor B-chain retrovirus. Cancer Res 58: 5275–5279, 1998

    Google Scholar 

  45. Uhrbom L, Hesselager G, Östman A, Nistér M, Westermark B: Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells. Int J Cancer 85: 398–406, 2000

    Google Scholar 

  46. Holland EC, Hively WP, DePinho RA, Varmus HE: Aconstitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev 12: 3675–3685, 1998

    Google Scholar 

  47. Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J: Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313: 144–147, 1985

    Google Scholar 

  48. Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B: Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci USA 84: 6899–6903, 1987

    Google Scholar 

  49. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE, Fuller GN: Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25: 55–57, 2000

    Google Scholar 

  50. Holland EC, Li Y, Celestino J, Dai C, Schaefer L, Sawaya RA, Fuller GN: Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo. Am J Pathol 157: 1031–1037, 2000

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Cell Biology, Neurosurgery, and Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Lene Uhrbom & Eric C. Holland

Authors
  1. Lene Uhrbom
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric C. Holland
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uhrbom, L., Holland, E.C. Modeling Gliomagenesis with Somatic Cell Gene Transfer using Retroviral Vectors. J Neurooncol 53, 297–305 (2001). https://doi.org/10.1023/A:1012208314436

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012208314436

Search

Navigation